Cell Imaging and Culture Facilities

O'Donnell EF, Kopparapu PRao, Koch DC, Jang HSang, Phillips JLynne, Tanguay RL, Kerkvliet NI, Kolluri SKumar.  2012.  The aryl hydrocarbon receptor mediates leflunomide-induced growth inhibition of melanoma cells.. PLoS One. 7(7):e40926.

O'Donnell EF, Saili KS, Koch DC, Kopparapu PR, Farrer D, Bisson WH, Mathew LK, Sengupta S, Kerkvliet NI, Tanguay RL et al..  2010.  The anti-inflammatory drug leflunomide is an agonist of the aryl hydrocarbon receptor.. PLoS One. 5(10)

Marshall NB, Kerkvliet NI.  2010.  Dioxin and immune regulation: emerging role of aryl hydrocarbon receptor in the generation of regulatory T cells.. Ann N Y Acad Sci. 1183:25-37.

Kerkvliet NI, Steppan LB, Vorachek W, Oda S, Farrer D, Wong CP, Pham D, Mourich DV.  2009.  Activation of aryl hydrocarbon receptor by TCDD prevents diabetes in NOD mice and increases Foxp3+ T cells in pancreatic lymph nodes.. Immunotherapy. 1(4):539-47.

Funatake CJ, Ao K, Suzuki T, Murai H, Yamamoto M, Fujii-Kuriyama Y, Kerkvliet NI, Nohara K.  2009.  Expression of constitutively-active aryl hydrocarbon receptor in T-cells enhances the down-regulation of CD62L, but does not alter expression of CD25 or suppress the allogeneic CTL response.. J Immunotoxicol. 6(3):194-203.